Setting global targets could cut impact of diabetes in developing countries

diabetes
Credit: Unsplash/CC0 Public Domain

Setting and achieving targets for treating diabetes patients with cholesterol or blood pressure medication, as well as tackling blood sugar levels, could save lives and reduce healthy-lifetime lost due to diabetes in developing countries, a new global study reveals.

Some 80% of people with diabetes live in Low- and Middle-income Countries (LMICs). Fewer than 6% of these individuals can access the care they need to manage their diabetes and prevent long-term complications like heart attacks, strokes, kidney diseases or blindness.

Researchers have found that if 80% of people had their diabetes and high blood pressure—which often accompanies the condition—diagnosed, treated, and controlled, and were given a cholesterol medication, healthy lifetime lost to patients from diabetes would improve by around by 6% over 10 years. This would be mainly from reduced , like heart attacks or strokes.

The international research team, co-led by the University of Birmingham, published its findings today in The Lancet Global Health.

Co-lead author Professor Justine Davies, from the University of Birmingham’s Institute of Applied Health Research, commented: “We had already identified huge drop offs in the care received by people with diabetes in LMICs—from being diagnosed to being treated then having their condition managed, with fewer than 10% of patients getting the management they need.

“Setting global targets for HIV and AIDs has led to massive improvements in people getting the treatment that they need to save lives and improve health. Our research suggests that similar targets would certainly be useful in improving lives for people with diabetes. We must definitely now achieve scale-up blood pressure and statin medication treatment as part of our ongoing fight against diabetes.”

Benefits vary dependent on world region. For example, Central and Eastern Europe would derive most benefit from hitting targets, whereas countries in Oceania are already close to achieving these targets.

Hitting targets also would reduce deaths over the coming 10 years in all world regions, but the benefits are larger in some than others. For example, Eastern sub-Saharan Africa is the region with the most deaths from cardiovascular diseases due to diabetes at baseline (46 deaths per 1,000 people with diabetes) – if targets were achieved, deaths would fall to 27 per 1,000.

Analyzing health data from 23,678 people with diabetes in 67 countries, researchers estimate that achieving targets to improve the number of patients with diabetes who have their pressure properly treated and who are on a cholesterol medication, are among the most critical strategies for reducing diabetes complications in Low- and Middle Income Countries (LMICs). Boosting statin or treatment by 10% would substantially cut the risk of cardiovascular events whilst boosting control of glucose had less benefit.

Researchers also discovered that when considering costs, achieving such targets in most world regions would come in below WHO thresholds for cost effectiveness.

The study reveals that taking such an holistic approach and treating diabetes and as well as giving a cholesterol medication is cost effective, but it is likely to be more complex to monitor whether counties are achieving these multiple targets. It requires countries to regularly collect nationally representative data in order to monitor how effectively diabetes care is reaching patients.

“The study has highlighted some of the most important gaps in current global diabetes data that are needed both to establish targets for diabetes care in LMICs and monitor progress toward achieving these,” added Dr. Jennifer Manne-Goehler, co-lead author from the Brigham and Women’s Hospital and Harvard Medical School.

“Until diabetes registries are established, it is vital to collect data that will help us to assess the prevalence of diabetes and other cardiovascular disease risk factors in populations. The greater impact of COVID in people with reinforces this urgency.”



More information: Estimated impact of increased diagnosis, treatment, and control of diabetes mellitus among low- and middle-income countries: A microsimulation model, The Lancet Global Health (2021).

Citation: Setting global targets could cut impact of diabetes in developing countries (2021, September 22) retrieved 5 October 2021 from https://medicalxpress.com/news/2021-09-global-impact-diabetes-countries.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Your Risk of COVID-Linked Smell Loss Is Much Lower Now thumbnail

Your Risk of COVID-Linked Smell Loss Is Much Lower Now

Please enable cookies. Error 1005 Ray ID: 7e97a7aeec8c8596 • 2023-07-20 02:08:12 UTC What happened? The owner of this website (www.webmd.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 7e97a7aeec8c8596 • Your IP: 89.117.245.16 •
Read More
Cardiac Arrest Survival Lower in COVID-19 Inpatients thumbnail

Cardiac Arrest Survival Lower in COVID-19 Inpatients

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Survival after in-hospital cardiac arrest was roughly one-third lower in patients with COVID-19 infections compared to uninfected patients, based on data from nearly 25,000 individuals. Survival rates of less than 3% were reported in the United States and China for patients…
Read More
Must work without disruption, allow companies to provide booster doses to employees: Kiran Mazumdar-Shaw thumbnail

Must work without disruption, allow companies to provide booster doses to employees: Kiran Mazumdar-Shaw

Biocon Chief Kiran Mazumdar-Shaw urges PM Modi to allow companies to provide booster doses to employees. (Photo for representation. Picture credit: PTI)A day after Biocon executive chairperson Kiran Mazumdar-Shaw took to Twitter and urged Prime Minister Narendra Modi to allow companies to provide booster doses of the Covid-19 vaccine to their employees, India Today TV…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?

Total
0
Share